Development of Carbohydrate Polyelectrolyte Nanoparticles for Use in Drug Delivery Systems that Cross the Blood-Brain Barrier to Treat Brain Tumors.
Fuente:
PubMed
Enregistré dans:
| Auteurs principaux: | Silant'ev, Vladimir E, Shmelev, Mikhail E, Belousov, Andrei S, Trukhin, Fedor O, Struppul, Nadezhda E, Patlay, Aleksandra A, Kravchenko, Anna K, Shchava, Sergey P, Kumeiko, Vadim V |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Polymers
2025
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Superparamagnetic Nanoparticles Targeting Brain Cancer: Innovations in Carbohydrate-Based Coatings and Magnetic Field Guidance.
par: Alobaidi, Ahmed Mahdi Abed, et autres
Publié: (2026)
par: Alobaidi, Ahmed Mahdi Abed, et autres
Publié: (2026)
Marine Lectins and Lectin-like Proteins as Promising Molecules Targeting Aberrant Glycosylation Signatures in Human Brain Tumors.
par: Buriak, Ivan, et autres
Publié: (2024)
par: Buriak, Ivan, et autres
Publié: (2024)
New estimations of the relation between the alpha-effect and magnetic field fluctuations
par: N. A. Silant´ev
Publié: (2000)
par: N. A. Silant´ev
Publié: (2000)
IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components.
par: Shmelev, Mikhail E, et autres
Publié: (2024)
par: Shmelev, Mikhail E, et autres
Publié: (2024)
Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
par: Xudong Cai, et autres
Publié: (2024)
par: Xudong Cai, et autres
Publié: (2024)
Carbohydrates in waters and sediments
par: Artem'ev, Vladlen E
Publié: (1976)
par: Artem'ev, Vladlen E
Publié: (1976)
Carbohydrates in particulate matter of the Northwest Pacific
par: Artem'ev, Vladlen E
Publié: (1973)
par: Artem'ev, Vladlen E
Publié: (1973)
(Table 1) Carbohydrates in different sediment types of the Central Pacific
par: Artem'ev, Vladlen E
Publié: (1970)
par: Artem'ev, Vladlen E
Publié: (1970)
Delivery and Developmental Strategies for Enhanced Blood–Brain Barrier Permeation—A Review
par: Prem Selvaraj, et autres
Publié: (2025)
par: Prem Selvaraj, et autres
Publié: (2025)
Assessing Blood‐Brain Barrier Integrity in Alzheimer’s Mouse Models: Implications for Therapeutic Delivery
par: Ehsan Nozohouri, et autres
Publié: (2025)
par: Ehsan Nozohouri, et autres
Publié: (2025)
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
par: Mohammad Beygi, et autres
Publié: (2024)
par: Mohammad Beygi, et autres
Publié: (2024)
Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
par: Callan D. McLoughlin, et autres
Publié: (2024)
par: Callan D. McLoughlin, et autres
Publié: (2024)
Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
par: Callan D. McLoughlin, et autres
Publié: (2024)
par: Callan D. McLoughlin, et autres
Publié: (2024)
Across Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders
par: Luisa Bandeira Binder, et autres
Publié: (2025)
par: Luisa Bandeira Binder, et autres
Publié: (2025)
Blood‐Brain Barrier Dysfunction in Adults With Heart Failure
par: Bhaswati Roy, et autres
Publié: (2025)
par: Bhaswati Roy, et autres
Publié: (2025)
Crossing the Blood–Brain Barrier: Molecular Imaging Illuminates Transplanted Stem Cells in the Brain
par: Peili Cen, et autres
Publié: (2026)
par: Peili Cen, et autres
Publié: (2026)
Blood Brain Barrier‐Crossing Delivery of Felodipine Nanodrug Ameliorates Anxiety‐Like Behavior and Cognitive Impairment in Alzheimer's Disease
par: Xiaofei He, et autres
Publié: (2024)
par: Xiaofei He, et autres
Publié: (2024)
In Silico Modeling of Acoustic Microbubble Dynamics to Optimize Blood‐Brain Barrier Disruption for Safe Drug Delivery in Alzheimer’s Treatment
par: Folasewa Maryam Abdulsalam, et autres
Publié: (2025)
par: Folasewa Maryam Abdulsalam, et autres
Publié: (2025)
Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy
par: Ranjit De, et autres
Publié: (2025)
par: Ranjit De, et autres
Publié: (2025)
Establishment of a Four‐Cell In Vitro Blood‐Brain Barrier Model With Human Primary Brain Cells
par: Johid R. Malik, et autres
Publié: (2024)
par: Johid R. Malik, et autres
Publié: (2024)
Nanoparticles Coated with Brain Microvascular Endothelial Cell Membranes can Target and Cross the Blood–Brain Barrier to Deliver Drugs to Brain Tumors
par: Huajian Chen, et autres
Publié: (2024)
par: Huajian Chen, et autres
Publié: (2024)
Isolation and Characterization of Cultivable Microbes from the Gut of (Coleoptera: Tenebrionidae) Larvae Reared on Two Types of Artificial Diets.
par: Baklanova, Vladislava, et autres
Publié: (2025)
par: Baklanova, Vladislava, et autres
Publié: (2025)
Tea and Blood–Brain Barrier Homeostasis: Potential Mechanisms and Improvement Strategies
par: Rongbosen Yue, et autres
Publié: (2025)
par: Rongbosen Yue, et autres
Publié: (2025)
Diabetes Mellitus Impairs Blood‐Brain Barrier Integrality and Microglial Reactivity
par: Shaojun Liu, et autres
Publié: (2025)
par: Shaojun Liu, et autres
Publié: (2025)
Blood Brain Barrier permeability change in clinical stages of Alzheimer disease
par: Wanyong Shin, et autres
Publié: (2025)
par: Wanyong Shin, et autres
Publié: (2025)
Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development
par: Atharva R. Mulay, et autres
Publié: (2024)
par: Atharva R. Mulay, et autres
Publié: (2024)
Argonaute 2 in Neurons is essential for healthy Blood Brain Barrier Formation
par: Chandan Sona, et autres
Publié: (2024)
par: Chandan Sona, et autres
Publié: (2024)
Brain Pericytes and Wnt/β‐Catenin Signaling Induce Functional Blood–Brain Barrier Phenotype in Human iPSC‐Derived Model
par: Henrique Nogueira Pinto, et autres
Publié: (2026)
par: Henrique Nogueira Pinto, et autres
Publié: (2026)
Elevated Blood Biomarkers of Neurodegeneration and Blood Brain Barrier Dysfunction Correlate with Lower MRI Regional Brain Volumes Two Years after COVID‐19
par: Jennifer A. Frontera, et autres
Publié: (2024)
par: Jennifer A. Frontera, et autres
Publié: (2024)
Elevated Blood Biomarkers of Neurodegeneration and Blood Brain Barrier Dysfunction Correlate with Lower MRI Regional Brain Volumes Two Years after COVID‐19
par: Jennifer A. Frontera, et autres
Publié: (2024)
par: Jennifer A. Frontera, et autres
Publié: (2024)
Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases
par: Yuexia Yang, et autres
Publié: (2026)
par: Yuexia Yang, et autres
Publié: (2026)
Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases
par: Yuexia Yang, et autres
Publié: (2026)
par: Yuexia Yang, et autres
Publié: (2026)
Esketamine Protects the Blood–Brain Barrier Against Sepsis‐Associated Brain Injury by Regulating the BDNF/TrkB Pathway
par: Weiqin Wei, et autres
Publié: (2025)
par: Weiqin Wei, et autres
Publié: (2025)
Metabolomic Markers and Pathways of Blood–Brain Barrier Damage: A Systematic Review
par: Andrzej Wasilewski, et autres
Publié: (2025)
par: Andrzej Wasilewski, et autres
Publié: (2025)
Dolutegravir Inhibits Autophagy In Vitro in a Mouse Blood–Brain Barrier Model
par: Chang Huang, et autres
Publié: (2025)
par: Chang Huang, et autres
Publié: (2025)
An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis
par: Christina Schofield, et autres
Publié: (2024)
par: Christina Schofield, et autres
Publié: (2024)
A Random Forest Regression Model for Predicting Blood–Brain Barrier Permeability
par: Xinliang Yu
Publié: (2026)
par: Xinliang Yu
Publié: (2026)
Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights
par: Valerio Taggi, et autres
Publié: (2025)
par: Valerio Taggi, et autres
Publié: (2025)
Markers of Blood‐Brain Barrier Permeability and Immune Exhaustion are Present in Patients with Post‐COVID‐19 Brain Fog Compared to Controls
par: Jennifer A. Frontera, et autres
Publié: (2025)
par: Jennifer A. Frontera, et autres
Publié: (2025)
Prevalence and Intensity of sp. Infection in and Its Impact on the Immune Status of Bivalves.
par: Tsoy, Elizaveta, et autres
Publié: (2025)
par: Tsoy, Elizaveta, et autres
Publié: (2025)
Documents similaires
-
Superparamagnetic Nanoparticles Targeting Brain Cancer: Innovations in Carbohydrate-Based Coatings and Magnetic Field Guidance.
par: Alobaidi, Ahmed Mahdi Abed, et autres
Publié: (2026) -
Marine Lectins and Lectin-like Proteins as Promising Molecules Targeting Aberrant Glycosylation Signatures in Human Brain Tumors.
par: Buriak, Ivan, et autres
Publié: (2024) -
New estimations of the relation between the alpha-effect and magnetic field fluctuations
par: N. A. Silant´ev
Publié: (2000) -
IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components.
par: Shmelev, Mikhail E, et autres
Publié: (2024) -
Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
par: Xudong Cai, et autres
Publié: (2024)